01-07-2019 | Rituximab | Original Article
Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia
Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2019
Login to get access